Deerfield Management Company, L.P. (Series C) has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $4.04 Billion distributed in 106 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $1.41B, Viatris Inc with a value of $299M, Centene Corp with a value of $162M, Oscar Health, Inc. with a value of $159M, and Revolution Medicines, Inc. with a value of $143M.

Examining the 13F form we can see an decrease of $1.34B in the current position value, from $5.38B to 4.04B.

Deerfield Management Company, L.P. (Series C) is based out at New York, NY

Below you can find more details about Deerfield Management Company, L.P. (Series C) portfolio as well as his latest detailed transactions.

Portfolio value $4.04 Billion
Healthcare: $4.04 Billion
Consumer Defensive: $337,000
Energy: $236,000
Consumer Cyclical: $225,000
Industrials: $205,000
Real Estate: $112,000
Technology: $98,000
Financial Services: $79,000
Other: $78,000

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 106
  • Current Value $4.04 Billion
  • Prior Value $5.38 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 22 stocks
  • Additional Purchases 25 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 25 stocks
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.